Thyrocare Technologies Limited

NSE THYROCARE.NS

Thyrocare Technologies Limited Free Cash Flow Yield on February 07, 2025: 2.58%

Thyrocare Technologies Limited Free Cash Flow Yield is 2.58% on February 07, 2025, a -4.94% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Thyrocare Technologies Limited 52-week high Free Cash Flow Yield is 3.48% on June 04, 2024, which is 34.79% above the current Free Cash Flow Yield.
Thyrocare Technologies Limited 52-week low Free Cash Flow Yield is 1.91% on January 06, 2025, which is -26.08% below the current Free Cash Flow Yield.
Thyrocare Technologies Limited average Free Cash Flow Yield for the last 52 weeks is 2.63%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: THYROCARE.NS

Thyrocare Technologies Limited

CEO	Mr. Rahul Franklin Guha
IPO Date	May 10, 2016
Location	India
Headquarters	D/37-3, TTC Industrial Area
Employees	1,693
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Dental Care Medical Instruments Personal Care Pharmaceuticals Telehealth

Description

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Key trends

Past 5 years